The role of antibodies against hsp90 in the treatment of fungal infections

Drug News and Perspectives

Volumn 16, Issue 4, 2003, Pages 205-210

  Burnie, James ^a   Matthews, Ruth ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCONAZOLE; HEAT SHOCK PROTEIN 90 ANTIBODY; MICAFUNGIN; RECOMBINANT ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIFUNGAL ACTIVITY; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BACILLUS SUBTILIS; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CRYPTOCOCCUS NEOFORMANS; ESCHERICHIA COLI; HISTOPLASMA CAPSULATUM; HUMAN; IMMUNOTHERAPY; MYCOSIS; NONHUMAN; REVIEW; SACCHAROMYCES CEREVISIAE; SIDE EFFECT; VIRULENCE;

ANIMALS; ANTIBODIES; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MYCOSES;

EID: 0041431054     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2003.16.4.829331     Document Type: Review

References (49)

1. Casadevall, A. and Scharff, M.D. Antibody-based therapies for emerging infectious diseases. Emerging Infect Dis 1996, 2: 200-8.
2. Breedveld, F.C. Therapeutic monoclonal antibodies. Lancet 2000, 355: 735-40.
3. Kontoyiannis, D.P. and Lewis, R.E. Antifungal drug resistance of pathogenic fungi. Lancet 2002, 359: 1135-44.
4. Edwards, J.E. Invasive Candida infections - Evolution of a fungal pathogen. N Engl J Med 1991, 324: 1060-2.
5. Edmond, M.B., Wallace, S.E., McClish D.K., Pfaller, M.A., Jones, R.N. and Wenzel, R.P. Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis 1999, 29: 239-44.
6. Casadevall, A. Antibody immunity and invasive fungal infections. Infect Immun 1995, 63: 4211-8.
7. Matthews, R. and Burnie, J. Antibodies against Candida: Potential therapeutics? Trends Microbiol 1996, 4: 354-8.
8. Matthews R.C, Bumie J.P. and Tabaqchali, S. Immunblot analysis of the serological response in systemic candidiosis. Lancet 1984, 2: 1415-8.
9. Matthews R.C., Bumie J.P. and Tabaqchali, S. Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin Microbiol 1987, 25: 230-7.
10. Matthews, R.C. and Bumie, J.P. Cloning of a DNA sequence encoding a major fragment of the 47 kilodalton stress protein homologue of Candida albicans. FEMS Microbiol Lett 1989, 60: 25-30.
11. Matthews, R., Bumie, J., Smith, D., Clark, I., Midgley, J., Connolly, M. and Gazzard, B. Candida and AIDS: Evidence for protective antibody. Lancet 1988, 101: 263-6.
12. Peterson, P., Perheentupa, J. and Krohn, K.J.E. Detection of candidal antigens in autoimmune polyglandular syndrome type I. Clin Diagn Lab Immunol 1996, 3: 290-4.
13. Swoboda, R.K., Bertram, G., Budge, S., Gooday, G.W., Gow, N.A.R. and Brown, A.J.P. Structure and regulation of the HSP90 gene from the pathogenic fungus Candida albicans. Infect Immun 1995, 63: 4506-14.
14. Matthews, R.C. HSP90, yeast and Corynebacterium jeikeium. Epidemiol Infect 1991, 107: 273-83.
15. Csermely, P., Schnaider, T., Soti, C., Prohaszka, Z. and Nardai, G. The 90 kDa molecular chaperone family: Structure, function and clinical applications. A comprehensive review. Pharmacol Ther 1998, 79: 129-68.
16. Matthews, R.C., Maresca, B., Burnie, J.P. et al. Stress proteins in fungal diseases. Med Mycol 1998, 36(Suppl 1): 45-51.
17. Wallin, R.P., Moré, S.H., Lundqvist, A., von Bonin, A., Kiessling, R. and Ljunggren, H.G. Heat-shock proteins as activators of the innate immune system. Trends Immunol 2002, 23: 130-2.
18. Bonnefoy, S., Gysin, J., Blisnick, T. et al. Immunogenicity of a Plasmodium falciparum protein fraction (90-110kDa) able to protect squirrel monkeys against asexual blood stages. Vaccine 1994, 12: 32-40.
19. Matthews, R. and Burnie, J. The role of hsp90 in fungal infections. Immunol Today 1992, 13: 345-8.
20. Borkovich, K.A., Farrelly, F.W., Finkelstein, D.B. and Taulien, S. Hsp82 is an essential protein that is required at higher temperatures. Mol Cell Biol 1989, 9: 3919-30.
21. Hodgetts, S., Matthews, R.C., Morrissey, G., Mitsutake, K. and Burnie J.P. Over-expression of Saccharomyces cerevisiae hsp90 enhances virulence of this yeast in mice. FEMS Immunol Med Microbiol 1996, 16: 229-34.
22. Brunt, S.A., Riehl, R. and Silver, J.C. Steroid hormone regulation of the Achyla ambisexualis 85-kilodalton heat shock protein, a component of the Achyla steroid receptor complex. Mol Cell Biol 1990, 10: 273-81.
23. Girvitz, T.L., Quimet, P.M. and Kapoor, M. Heat shock protein 80 of Neurospora crassa: Sequence analysis of the gene and expression during the asexual phase. Can J Microbiol 2000, 46: 981-91.
24. Grandin, N. and Charbonneau, M. Hsp90 levels affect telomere length in yeast. Mol Genet Genomics 2001, 265: 126-34.
25. Harris, N., Maclean, M., Hatzianthis, K., Panaretou, B. and Piper, P.W. Increasing Saccharomyces cerevisiae stress resistance, through the over activation of the heat shock response resulting from defects in the Hsp90 chaperone, does not extend replicative life span but can be associated with slower chronological ageing of nondividing cells. Mol Genet Genomics 2001, 265: 258-63.
26. Nathan, D.E, Vos, M.H. and Lindquist, S. In vivo functions of the Saccharomyces cerevisiae hsp90 chaperone. Proc Natl Acad Sci USA 1997, 94: 12949-56.
27. Goes, S.G. and Martin, J. Hsp90 chaperone complexes are required for the activity and stability of yeast protein kinases Mik1, Wee1 and Swe1. Eur J Biochem 2001, 268: 2281-9.
28. Guigar, P.R., Finucanem, M. and Larsenn, B. The effect of estradiol on Candida albicans growth. Ann Clin Lab Sci 1997, 27: 151-6.
29. Bramley, TA., Menzies, G.S., Williams, R.J., Adams, D.J. and Kinsman, O.S. Specific, high-affinity binding sites for human luteinizing hormone (LH) and human chorionic gonadotrophin (hCG) in Candida species. Biochem Biophys Res Commun 1990, 167: 1050-6.
30. Zhang, K., Essmann, M., Burt, E.T. and Larsen, B. Estrogen effects on Candida albicans: A potential virulence-regulating mechanism. J Infect Dis 1999, 181: 1441-6.
31. Krishnamurthy, S., Gupta, V., Prasad, R. et al. Expression of CDR1, a multidrug resistance gene of Candida albicans: Transcriptional activation by heat shock, drugs and human steroid hormones. FEMS Lett 1998, 160: 191-7.
32. Louvion, J.-F., Abbas-Terki, T. and Picard, D. Hsp90 is required for pheromone signalling in yeast. Mol Biol Cell 1998, 9: 3071-83.
33. Yazdanyar, A., Essmann, M. and Larsen, B. Genistein effects on growth and cell cycle of Candida albicans. J Biomed Sci 2001, 8: 153-9.
34. Hickey, E., Brandon, S.E., Sadis, S., Smale, G. and Weber, L.A. Molecular cloning of sequences encoding the human heat-shock proteins and their expression during hyperthermia. Gene 1986, 43: 147-54.
35. Garcia-Cardena, G., Fan, R., Shah, V. et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998, 392: 821-4.
36. Shastry, S. and Joyner, M.J. Geldanamycin attenuates NO-mediated dilation in human skin. Am J Physiol Heart Circ Physiol 2002, 282: 232-6.
37. Moncada, S., Palmer, R.M. and Higgs, E.A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991, 43: 109-42.
38. Kusumam, J., Tholanikummel, B.G. and Kaplan, A.P. Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor. Proc Natl Acad Sci USA 2002, 99: 896-900.
39. Lopatin, D.E., Combs, A., Sweier, D.G., Fenno, J.C. and Dhamija, S. Characterization of heat-inducible expression and cloning of HtpG (Hsp90 homologue) of Porphyromonas gingivalis. Infect Immun 2000, 68: 1980-7.
40. Matthews, R.C., Burnie, J.P. and Lee, W. The application of epitope mapping in the development of a new serological test for systemic candidosis. J Immunol Methods 1991, 143: 73-9.
41. Al-Dughaym, A.M., Matthews, R.C. and Bumie, J.P. Epitope mapping human heat shock protein 90 with sera from infected patients. FEMS Immunol Med Micro 1994, 8: 43-8.
42. Matsumoto, S., Tanaka, E., Nemoto, T.K. et al. Interaction between the N-terminal and middle region is essential for the in vivo function of Hsp90 molecular chaperone. J Biol Chem 2002, 277:34959-66.
43. Louvion, J.F., Warth, R. and Picard, D. Two eukaryote-specific regions of hsp82 are dispensable for its viability and signal transduction functions in yeast. Proc Natl Acad Sci USA 1996, 93: 1297-302.
44. Söti, C., Rácz, A. and Csermely, P. A nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of HSP90. J Biol Chem 2002, 277: 7066-75.
45. Dutta, R. and Inouye, M. GHKL, an emergent ATPase/kinase supelfamily. Trends Biochem Sci 2000, 25: 24-8.
46. Matthews, R., Burnie J.P., Howat D., Rowland T. and Walton F. Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology 1991, 74: 20-4.
47. Matthews, R., Hodgetts S. and Bumie, J. Preliminary assessment of a human recombinant antibody fragment to hsp90 murine invasive candidiasis. J Infect Dis 1995, 171: 1668-71.
48. Matthews, R. and Bumie, J. Antifungal antibodies: A new approach to the treatment of systemic candidiasis. Curr Opin Invest Drugs 2001, 2: 472-6.
49. Stencal, C. Experts probe complexity of Candida. ASM News 1999, 65: 542-6.